Relapse/Refractory Mantle Cell Lymphoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB15699Brexucabtagene autoleucelNot AvailableApproved for Marketing1
DB00531CyclophosphamideNot AvailableApproved for Marketing1
DB01073FludarabineNot AvailableApproved for Marketing1